Market Value641,721,000
Total Holdings72
File Date2021-11-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
AVIR / Atea Pharmaceuticals, Inc.
ATXS / Astria Therapeutics, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
KRYS / Krystal Biotech, Inc.
NGM / NGM Biopharmaceuticals, Inc.
NTRA / Natera, Inc.
LNTH / Lantheus Holdings, Inc.
BEAM / Beam Therapeutics Inc.
PAYX / Paychex, Inc.
CUTR / Cutera, Inc.
FLXN / Horizon Funds - Horizon Flexible Income ETF
DALS / DA32 Life Science Tech Acquisition Corp - Class A
ESTA / Establishment Labs Holdings Inc.
ASMB / Assembly Biosciences, Inc.
TVTX / Travere Therapeutics, Inc.
/ RENALYTIX AI PLC-ADR DEPOSITARY RECEIPT
RPTX / Repare Therapeutics Inc.
ANGO / AngioDynamics, Inc.
BCAB / BioAtla, Inc.
SLGC / Standard BioTools Inc.
CAREMAX INC / COM CL A (14171W103)
MSON / Misonix Inc
US38341PAA03 / Gossamer Bio Inc
HOWL / Werewolf Therapeutics, Inc.
RFL / Rafael Holdings, Inc.
GLUE / Monte Rosa Therapeutics, Inc.
PRCT / PROCEPT BioRobotics Corporation
US10806XAB82 / Bridgebio Pharma, Inc.
ARYD / ARYA Sciences Acquisition Corp IV
EDIT / Editas Medicine, Inc.
KDMN / Kadmon Holdings Inc
MGTA / Magenta Therapeutics Inc
INSP / Inspire Medical Systems, Inc.
CTMX / CytomX Therapeutics, Inc.
RVMD / Revolution Medicines, Inc.
EDAP / EDAP TMS S.A. - Depositary Receipt (Common Stock)
AXGN / Axogen, Inc.
EPIX / ESSA Pharma Inc.
TCRR / Tcr2 Therapeutics Inc
ZGNX / Zogenix Inc
CDMO / Avid Bioservices, Inc.
PIRS / Pieris Pharmaceuticals, Inc.
CDNA / CareDx, Inc
BVS / Bioventus Inc.
ARNA / Arena Pharmaceuticals Inc
PCRX / Pacira BioSciences, Inc.
SIEN / Sientra, Inc.
VIVO / Meridian Bioscience Inc.
HALO / Halozyme Therapeutics, Inc.
TKNO / Alpha Teknova, Inc.
GH / Guardant Health, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
NVCR / NovoCure Limited
CORT / Corcept Therapeutics Incorporated
ISEE / IVERIC bio Inc
CTSO / Cytosorbents Corporation
VNDA / Vanda Pharmaceuticals Inc.
NEO / NeoGenomics, Inc.
MDXG / MiMedx Group, Inc.
DXCM / DexCom, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
GLTO / Galecto, Inc.
EIGR / Eiger BioPharmaceuticals, Inc.
CRSP / CRISPR Therapeutics AG
DICE / DICE Therapeutics Inc
SPRY / ARS Pharmaceuticals, Inc.
ENTA / Enanta Pharmaceuticals, Inc.
LUNG / Pulmonx Corporation
FDMT / 4D Molecular Therapeutics, Inc.
INBX / Inhibrx Biosciences, Inc.
NARI / Inari Medical, Inc.
CVRX / CVRx, Inc.
SKIN / The Beauty Health Company
NPCE / NeuroPace, Inc.
PODD / Insulet Corporation
IRMD / IRADIMED CORPORATION
PCVX / Vaxcyte, Inc.
XENE / Xenon Pharmaceuticals Inc.
LYRA / Lyra Therapeutics, Inc.
DYN / Dyne Therapeutics, Inc.
NRIX / Nurix Therapeutics, Inc.
UTHR / United Therapeutics Corporation
EOLS / Evolus, Inc.
EWTX / Edgewise Therapeutics, Inc.
YMAB / Y-mAbs Therapeutics, Inc.
ORGO / Organogenesis Holdings Inc.
THTX / Theratechnologies Inc.
SRDX / Surmodics, Inc.
CCCC / C4 Therapeutics, Inc.
CELC / Celcuity Inc.